Efficient spin transport through native oxides of nickel and permalloy with platinum and gold overlayers

We present measurements of spin pumping detected by the inverse spin Hall effect voltage and ferromagnetic resonance spectroscopy in a series of metallic ferromagnet/normal metal thin film stacks. We compare heterostructures grown in situ to those where either a magnetic or nonmagnetic oxide is introduced between the two metals. The heterostructures, either nickel with a platinum overlayer (Ni/Pt) or the nickel-iron alloy permalloy (Py) with a gold overlayer (Py/Au), were also characterized in detail using grazing-incidence x-ray reflectivity, Auger electron spectroscopy, and both SQUID and alternating-gradient magnetometry. We verify the presence of oxide layers, characterize layer thickness, composition, and roughness, and probe saturation magnetization, coercivity, and anisotropy. The results show that while the presence of a nonmagnetic oxide at the interface suppresses spin transport from the ferromagnet to the nonmagnetic metal, a thin magnetic oxide (here the native oxide formed on both Py and Ni) somewhat enhances the product of the spin-mixing conductance and the spin Hall angle. We also observe clear evidence of an out-of-plane component of magnetic anisotropy in Ni/Pt samples that is enhanced in the presence of the native oxide, resulting in perpendicular exchange bias. Finally, the dc inverse spin Hall voltages generated at ferromagnetic resonance in our Py/Au samples are large, and suggest values for the spin Hall angle in gold of 0.04<αSH<0.22, in line with the highest values reported for Au. This is interpreted as resulting from Fe impurities. We present indirect evidence that the Au films described here indeed have significant impurity levels.B.L.Z. and D.B. gratefully acknowledge support from the NSF (Grants No. DMR-0847796 and No. DMR-1410247). B.L.Z. also thanks the University of Minnesota Chemical Engineering and Materials Science Department, as a portion of this work benefited from support of the George T. Piercy Distinguished Visiting Professorship. Work at the University of Minnesota was supported primarily by the NSF under Grant No. DMR-1507048, with additional support from the NSF MRSEC under Grant No. DMR-1420013. The work at WMI is supported by Deutsche Forschungsgemeinschaft via SPP 1538 Spin-Caloric Transport (Project No. GO 944/4-1). Parts of this work were carried out in the Characterization Facility, University of Minnesota, which receives partial support from NSF through the MRSEC program. This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Los Alamos National Laboratory (Contract No. DE-AC52-06NA25396) and Sandia National Laboratories (Contract No. DE-AC04-94AL85000)

Publisher Correction: Non-tuberculous Mycobacteria isolated from Pulmonary samples in sub-Saharan Africa - A Systematic Review and Meta Analyses.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper

KAJIAN PENERAPAN SISTEM 'GREEN BUILDING' PADA GEDUNG WORKSHOP POLITEKNIK PU DI SEMARANG

Tujuan penelitian ini adalah mengevaluasi desain bangunan gedung Workshop Politeknik PU kota Semarang terhadap kemungkinan penerapan kaidah kaidah bangunan gedung hijau. Menganalisis dan memberi usulan kemungkinan pengajuan sertifikasi Green Building menurut persyaratan yang dikeluarkan oleh asosiasi Green Building Council Indonesia (GBCI). Tahapan metode penelitian antara lain mencari produk perencanaan dan desain bangunan gedung Workshop Politeknik PU kota Semarang. Mengobservasi produk tersebut meliputi latar belakang perencanaan, konsep dan desain fisik bangunan. Menggali data informasi tapak yang meliputi lokasi, lahan dan lingkungan sekitar. Selanjutnya melakukan evaluasi perencanaan dan desain berdasarkan persyaratan bangunan gedung hijau. Menilai kekurangan kelebihan dan pemenuhan terhadap persyaratan tersebut. Kemudian menganalisis kemungkinan penerapan berbagai syarat bangunan ngedung hijau dan mengusulkan penambahan-penambahan bagian- bagian fisik bangunan sesuai persyaratan bangunan gedung hijau. Serta mengusulkan kemungkinannya untuk diajukan sertifikasi Green Building berdasarkan asosiasi GBCI. Luaran yang ditargetkan adalah menyerahkan produk penelitian kepada pemerintah setempat untuk menjadi masukan dalam pengelolaan bangunan gedung Workshop Politeknik PU kota Semarang mengarah kepada persyaratan bangunan gedung hijau di kota Semarang

Tuberculous meningitis: new tools and new approaches required [version 1; peer review: not peer reviewed]

Tuberculous meningitis is the most severe form of tuberculosis and causes widespread mortality and morbidity. Understanding of the epidemiology and pathogenesis is incomplete, and the optimal diagnosis and treatment are poorly defined. To generate research collaboration and coordination, as well as to promote sharing of ideas and advocacy efforts, the International Tuberculous Meningitis Research Consortium was formed in 2009. During the most recent meeting of this group in Lucknow, India, in March 2019, the Consortium decided to bring together key articles on tuberculous meningitis in one supplement. The supplement covers recent scientific updates, expert perspectives on specific clinical challenges, consensus statements on how to conduct research, and a set of priorities for future investigation

The current global situation for tuberculous meningitis: Epidemiology, diagnostics, treatment and outcomes

Tuberculous meningitis (TBM) results from dissemination of M. tuberculosis to the cerebrospinal fluid (CSF) and meninges. Ischaemia, hydrocephalus and raised intracranial pressure frequently result, leading to extensive brain injury and neurodisability. The global burden of TBM is unclear and it is likely that many cases are undiagnosed, with many treated cases unreported. Untreated, TBM is uniformly fatal, and even if treated, mortality and morbidity are high. Young age and human immunodeficiency virus (HIV) infection are potent risk factors for TBM, while Bacillus Calmette-Guérin (BCG) vaccination is protective, particularly in young children. Diagnosis of TBM usually relies on characteristic clinical symptoms and signs, together with consistent neuroimaging and CSF parameters. The ability to confirm the TBM diagnosis via CSF isolation of M. tuberculosis depends on the type of diagnostic tests available. In most cases, the diagnosis remains unconfirmed. GeneXpert MTB/RIF and the next generation Xpert Ultra offer improved sensitivity and rapid turnaround times, and while roll-out has scaled up, availability remains limited. Many locations rely only on acid fast bacilli smear, which is insensitive. Treatment regimens for TBM are based on evidence for pulmonary tuberculosis treatment, with little consideration to CSF penetration or mode of drug action required. The World Health Organization recommends a 12-month treatment course, although data on which to base this duration is lacking. New treatment regimens and drug dosages are under evaluation, with much higher dosages of rifampicin and the inclusion of fluoroquinolones and linezolid identified as promising innovations. The inclusion of corticosteroids at the start of treatment has been demonstrated to reduce mortality in HIV-negative individuals but whether they are universally beneficial is unclear. Other host-directed therapies show promise but evidence for widespread use is lacking. Finally, the management of TBM within health systems is sub-optimal, with drop-offs at every stage in the care cascade

Knowledge gaps and research priorities in tuberculous meningitis [version 1; peer review: 3 approved]

Tuberculous meningitis (TBM) is the most severe and disabling form of tuberculosis (TB), accounting for around 1-5% of the global TB caseload, with mortality of approximately 20% in children and up to 60% in persons co-infected with human immunodeficiency virus even in those treated. Relatively few centres of excellence in TBM research exist and the field would therefore benefit from greater co-ordination, advocacy, collaboration and early data sharing. To this end, in 2009, 2015 and 2019 we convened the TBM International Research Consortium, bringing together approximately 50 researchers from five continents. The most recent meeting took place on 1st and 2nd March 2019 in Lucknow, India. During the meeting, researchers and clinicians presented updates in their areas of expertise, and additionally presented on the knowledge gaps and research priorities in that field. Discussion during the meeting was followed by the development, by a core writing group, of a synthesis of knowledge gaps and research priorities within seven domains, namely epidemiology, pathogenesis, diagnosis, antimicrobial therapy, host-directed therapy, critical care and implementation science. These were circulated to the whole consortium for written input and feedback. Further cycles of discussion between the writing group took place to arrive at a consensus series of priorities. This article summarises the consensus reached by the consortium concerning the unmet needs and priorities for future research for this neglected and often fatal disease

Management of intracranial tuberculous mass lesions: How long should we treat for? [version 2; peer review: 1 approved, 2 approved with reservations]

Tuberculous intracranial mass lesions are common in settings with high tuberculosis (TB) incidence and HIV prevalence. The diagnosis of such lesions, which include tuberculoma and tuberculous abscesses, is often presumptive and based on radiological features, supportive evidence of TB elsewhere and response to TB treatment. However, the treatment response is unpredictable, with lesions frequently enlarging paradoxically or persisting for many years despite appropriate TB treatment and corticosteroid therapy. Most international guidelines recommend a 9-12 month course of TB treatment for central nervous system TB when the infecting Mycobacterium tuberculosis (M.tb) strain is sensitive to first-line drugs. However, there is variation in opinion and practice with respect to the duration of TB treatment in patients with tuberculomas or tuberculous abscesses. A major reason for this is the lack of prospective clinical trial evidence. Some experts suggest continuing treatment until radiological resolution of enhancing lesions has been achieved, but this may unnecessarily expose patients to prolonged periods of potentially toxic drugs. It is currently unknown whether persistent radiological enhancement of intracranial tuberculomas after 9-12 months of treatment represents active disease, inflammatory response in a sterilized lesion or merely revascularization. The consequences of stopping TB treatment prior to resolution of lesional enhancement have rarely been explored. These important issues were discussed at the 3 International Tuberculous Meningitis Consortium meeting. Most clinicians were of the opinion that continued enhancement does not necessarily represent treatment failure and that prolonged TB therapy was not warranted in patients presumably infected with M.tb strains susceptible to first-line drugs. In this manuscript we highlight current medical treatment practices, benefits and disadvantages of different TB treatment durations and the need for evidence-based guidelines regarding the treatment duration of patients with intracranial tuberculous mass lesions

Mechanism, spectrum, consequences and management of hyponatremia in tuberculous meningitis

Hyponatremia is the commonest electrolyte abnormality in hospitalized patients and is associated with poor outcome. Hyponatremia is categorized on the basis of serum sodium into severe (< 120 mEq/L), moderate (120-129 mEq/L) and mild (130-134mEq/L) groups. Serum sodium has an important role in maintaining serum osmolality, which is maintained by the action of antidiuretic hormone (ADH) secreted from the posterior pituitary, and natriuretic peptides such as atrial natriuretic peptide and brain natriuretic peptide. These peptides act on kidney tubules via the renin angiotensin aldosterone system. Hyponatremia <120mEq/L or a rapid decline in serum sodium can result in neurological manifestations, ranging from confusion to coma and seizure. Cerebral salt wasting (CSW) and syndrome of inappropriate secretion of ADH (SIADH) are important causes of hyponatremia in tuberculosis meningitis (TBM). CSW is more common than SIADH. The differentiation between CSW and SIADH is important because treatment of one may be detrimental for the other; evidence of hypovolemia in CSW and euvolemia or hypervolemia in SIADH is used for differentiation. In addition, evidence of dehydration, polyuria, negative fluid balance as assessed by intake output chart, weight loss, laboratory evidence and sometimes central venous pressure are helpful in the diagnosis of these disorders. Volume contraction in CSW may be more protracted than hyponatremia and may contribute to border zone infarctions in TBM. Hyponatremia should be promptly and carefully treated by saline and oral salt, while 3% saline should be used in severe hyponatremia with coma and seizure. In refractory patients with hyponatremia, fludrocortisone helps in early normalization of serum sodium without affecting polyuria or functional outcome. In SIADH, V2 receptor antagonist conivaptan or tolvaptan may be used if the patient is not responding to fluid restriction. Fluid restriction in SIADH has not been found to be beneficial in TBM and should be avoided